1. Home
  2. RBNE vs EVGN Comparison

RBNE vs EVGN Comparison

Compare RBNE & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robin Energy Ltd.

RBNE

Robin Energy Ltd.

HOLD

Current Price

$0.67

Market Cap

4.7M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.43

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBNE
EVGN
Founded
2024
1999
Country
Cyprus
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RBNE
EVGN
Price
$0.67
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
527.0K
437.6K
Earning Date
04-10-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
$42.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.37
52 Week High
$5.29
$1.50

Technical Indicators

Market Signals
Indicator
RBNE
EVGN
Relative Strength Index (RSI) 27.40 28.20
Support Level N/A N/A
Resistance Level $0.94 $0.86
Average True Range (ATR) 0.06 0.04
MACD 0.01 -0.00
Stochastic Oscillator 21.25 25.96

Price Performance

Historical Comparison
RBNE
EVGN

About RBNE Robin Energy Ltd.

Robin Energy Ltd is engaged in the ownership and operation of vessels providing seaborne transportation of refined petroleum products and liquefied petroleum gas (LPG). The company operates in two reportable segments: the Tanker segment and the LPG carrier segment.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: